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Abstract. Two neurochemically distinct forms of stress-in- 
duced analgesia were examined in adult rats following 
prenatal ethanol exposure. Rats were exposed to ethanol 
during the last 2 weeks of gestation through a liquid diet 
presented to the dams. Analgesia testing was conducted 
when the offspring were 150-210 days of age. Two forms of 
footshock stress were administered; one that resulted in a 
naloxone-sensitive (opioid-mediated) analgesia and one 
that resulted in a naloxone-insensitive (nonopioid) form of 
analgesia. Rats prenatally exposed to ethanol demonstrated 
significantly enhanced opioid-mediated analgesia, but unal- 
tered nonopioid analgesia compared to controls. These 
results confirm previous findings that prenatal exposure to 
ethanol leads to long-term alterations in responding to 
some, but not all forms of stress. The possibility that 
prenatal exposure to ethanol leads to perturbations in the 
endogenous opioid systems is discussed. 
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Fetal exposure to ethanol has been shown to produce a 
spectrum of anatomical, physiological, and behavioral 
abnormalities in both humans and animals (Abel 1980; 
Rosett 1980; Streissguth et al. 1980). Controlled studies 
utilizing laboratory animals have demonstrated that, 
whereas some of the effects of prenatal exposure to alcohol 
are evident for only a conscribed period of time after birth, 
others persist throughout adulthood (Bond 1981; Druse 
1981). We have been studying the long-lasting effects of 
fetal exposure to ethanol on rat responses to pharmaco- 
logical agents and environmental stressors. For example, it 
has been shown that adult rats exposed prenatally to 
ethanol show an enhanced endocrine response, namely 
activation of the hypothalamo-pituitary adrenal axis, fol- 
lowing administration of ethanol (Taylor et al. 1981). In 
addition, fetal ethanol-exposed rats respond to certain 
stressors, but not others, with an enhanced release of 
adrenal corticosteroids (Taylor et al. 1982; Weinberg and 
Gallo 1982). In light of this evidence suggesting an altered 
endocrinological response to pharmacological and environ- 
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mental stressors in rats prenatally exposed to ethanol, we 
chose to investigate a behavioral response to stress; 
namely, stress-induced analgesia. 
Exposure to a variety of inescapable stressors has been 
shown to produce decreased sensitivity to pain as measured 
by several standard analgesiometric tests (Lewis et al. 1983 
for review). Lewis et al. (1980) showed that, depending on 
the temporal parameters of its administration, inescapable 
footshock can elicit qualitatively different forms of stress 
analgesia. In male Sprague-Dawley rats, intermittent foot- 
shock (20 rain) causes an analgesia that, by several criteria 
(i.e., reversal by naloxone, development of tolerance, 
cross-tolerance with morphine analgesia) appears to be 
mediated by opioid peptides and relies both on neural and 
hormonal systems. Continuous footshock (3 min), on the 
other hand, causes an analgesia that by these same criteria 
appears to be nonopioid in nature and independent of 
hormonal systems (Lewis et al. 1982). The present study 
compared opioid and nonopioid analgesic responses to 
footshock stress in rats prenatally exposed to ethanol and in 
controls. A preliminary report of these data has been 
published (Nelson et al. 1982). 
Materials and methods 
The subjects were adult female offspring, 150-210 days of 
age, derived from 73 timed-pregnant, nulliparous Spra- 
gue-Dawley rats received from Charles River Laboratories 
(Wilmington, MA) when 6 days pregnant. On day 8 of 
gestation, the dams were divided into weight-matched 
groups for subsequent feeding of the following three 
different diets: (1) ad libitum casein-supplemented liquid 
diet (Bioserv, Frenchtown, NJ) containing 5.0% w/v 
ethanol; (2) an isoealoric liquid diet (Bioserv) with maltose 
dextrin added to replace ethanol, pairfed to the amount 
consumed by the ethanol dams; (3) standard lab chow and 
water ad libitum. Fresh diet was presented daily at 9 AM 
from day 8 of gestation until parturition. Diet consumption 
was recorded daily and dams were weighed biweekly. On 
the day of birth, all pups in each prenatal treatment group 
(E = ethanol, PF = pairfed, N = none or normal) were 
culled, randomly placed into groups of 10, and fostered to 
dams which were fed the standard lab chow diet. The pups 
and dams were weighed at weekly intervals until weaning 
on postnatal day 21 when pups were group housed by sex. 
Female offspring (N = 36-44),  randomly selected from a 
total of approximately 105 in each prenatal treatment 
group, were used for these experiments. At 150-210 days 
of age, these offspring were placed on a 12-h reverse 
light-dark cycle (lights on 8 PM). After a 2-week acclima- 
tion period, behavioral testing was conducted 
(9AM-1PM).  
Experiment 1. Pain responsiveness was assessed using a 
modified version of the tail-flick test (D 'Amour  and Smith 
1941). A maximum response latency of 7 s was employed on 
all trials to prevent tissue damage in analgesic animals. 
Prior to footshock exposure, five tail-flick trials were 
conducted at l-rain intervals and the average of the last 
three trials defined baseline pain responsiveness. Foot- 
shock stress consisted of 2.5 mA 60-Hz sine waves 
scrambled and delivered to the grid floor of a 23-x 23-x 
23-cm Plexiglas chamber according to one of the following 
two procedures: intermittent footshock consisting of 1-s 
pulses delivered every 5 s for 10 min; continuous footshock 
for 2 rain. Tail-flick testing resumed 1 rain after footshock 
termination and continued at l-rain intervals for the first 9 
min, and at 2-rain intervals from 9 -15  rain poststress. Rats 
from each prenatal treatment group received either 10-min 
intermittent (n = 20, 15, and 12 for groups E, PF, and N, 
respectively) or 2-min continuous (n = 8 for each group) 
footshock stress. Data for the 10-rain intermittent foot- 
shock condition were collected in two independent exper- 
iments and the results were pooled. 
Experiment2. The purpose of this experiment was to assess 
the involvement of opioid peptides in the analgesic 
response to both 2-rain continuous and 10-rain intermittent 
footshock. Rats from each prenatal treatment group (n = 
16 for each group) were injected with either naloxone 
(2 mg/kg SC) or saline 5 min prior to baseline testing. To 
maintain an equal interval between drug injection and 
poststress analgesia testing (20 min), continuous footshock 
stress onset was delayed 8 min following baseline testing. 
Each rat was exposed to one form of footshock (2-min 
continuous or 10-min intermittent) on two occasions; once 
after saline and once after naloxone. The order of drug 
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administration was counterbalanced and the experimenter 
was blind to the drug condition. 
Data analysis. All tail-flick latency data were analyzed in 
two ways. Raw scores were subjected to analysis of variance 
for repeated measures and Tukey's tests for specific 
comparisons (Keppel 1973). Also, raw scores were trans- 
formed to total analgesia scores, calculated as the area 
between the poststress tail-flick latency curve and the 
baseline for each subject. These areas were also subjected 
to analysis of variance and Tukey's tests. Both methods of 
data analysis, raw scores and total analgesia scores, yielded 
the same statistical results in all cases. 
Results 
Experiment 1. As shown in Fig. 1, 10-min intermittent 
footshock stress caused marked analgesia, indicated by 
elevations in poststress tail-flick latencies in all groups. 
Analysis of variance of the raw scores or the total analgesia 
scores indicates that this analgesia was significantly greater 
in rats prenatally exposed to ethanol (F = 14.7, df 2,44; 
P <  0.01 compared to N or PF). In fact, as the total 
analgesia scores indicate, the analgesic response of the E 
rats was approximately twice that shown by either N or PF 
rats (Fig. 1). Tail-flick latencies following 2-min continuous 
footshock are shown in Fig. 2. Whereas the continuous 
footshock procedure was equipotent to the intermittent 
procedure in eliciting analgesia (compare total analgesia 
scores of normal offspring in Figs. 1 and 2), there were no 
differences in the analgesic response among the prenatal 
treatment groups following 2-rain continuous footshoek 
(Fig. 2). In no case did the groups differ significantly in 
baseline pain sensitivity (Figs. 1 and 2). 
Experiment 2. Figure 3 shows the analgesic response to 
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Fig. 1. The left half of the figure portrays the mean (+ SEM) tail-flick latencies at baseline testing (B) and following 10-rain intermittent 
footshock. The number in parentheses indicates the number of animals from each prenatal treatment group. The right half of the figure 
depicts the mean (_+ SEM) total analgesia scores for the same three groups (** indicates a significant difference between the groups at 
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treated rats. In Fig. 3, the data from the N and PF groups 
have been combined into a single control group for clarity 
of presentation, although they were separately analyzed 
statistically. At no time were the tail-flick latencies of the N 
and PF groups significantly different from each other. In all 
three prenatal treatment groups, naloxone significantly 
antagonized the analgesic response to 10-min intermittent 
footshock stress (F = 16.16, df5,42; P < 0.05, compared to 
saline in each case), suggesting the involvement of opioid 
peptides. Similar to the findings reported in experiment 1, 
the total analgesia scores indicate that prenatal ethanol-ex- 
posed rats were significantly more analgesic than control 
rats following 10-rain intermittent footshock when pre- 
treated with saline (F = 27.58, df 3,44, P < 0.01). How- 
ever, after pretreatment with naloxone and exposure to 
10-min intermittent footshock, there were no differences 
in tail-flick latencies among the prenatal treatment 
groups. 
In contrast to its effect on analgesia following 10-min 
intermittent footshock, naloxone pretreatment had no 
effect on analgesia following 2-min continuous footshock. 
Table 1 shows the mean total analgesia scores for each 
prenatal treatment group after saline or naloxone and 
2-min continuous footshock. Naloxone pretreatment did 
not reduce the total analgesia score of any of the prenatal 
treatment groups as compared to the analgesia that 
occurred following saline pretreatment. Additionally, there 
were no significant differences among the prenatal groups 
in either the saline or naloxone condition, which is in accord 
with the findings of experiment 1. Statistical analysis of the 
raw scores also yielded no significant differences between 
the groups. 
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Fig. 2. The left half of the figure portrays the mean (_+ SEM) tail-flick latencies at baseline testing (B) and following 2-rain continuous 
footshock. The number in parentheses indicates the number of animals from each prenatal treatment group. The right half of the figure 
depicts the mean (•  SEM) total analgesia scores of these same three groups 
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Fig. 3. The left half of the figure portrays the mean (•  SEM) tail-flick latencies at baseline (B) testing and following 10-min intermittent 
footshock preceded by either saline or naloxone (2mg/kg). Data from the N and PF animals were not significantly different and were 
combined into a single control group (C) for clarity of presentation. The number in parentheses indicates the number of animals from each 
prenatal treatment group. The right half of the figure depicts the mean (•  SEM) total analgesia scores of these same four 
groups 
95 
Table 1. Effect of naloxone (2 mg/kg) on analgesia following 2-rain 
continuous footshock 
Group" Total analgesia (s-min) b 
Ethanol - saline 
Ethanol - naloxone 
Pairfed - saline 
Pairfed - naloxone 
Normal - saline 
Normal - naloxone 
26.21 _+ 2.41 
23.44 + 3.28 
27.18 _+ 5.05 
29.00 + 2.27 
30.37 + 4.16 
24.41 + 3.10 
a n = 8 for each group 
b Values are means + SEM 
Discussion 
In female Sprague-Dawley rats, two paradigms of foot- 
shock presentation were found to elicit equipotent but 
pharmacologically different forms of stress-induced anal- 
gesia. Intermittent footshock stress produced a nalox- 
one-blockable analgesia, suggesting that this form of 
stress-induced analgesia is at least partially mediated by 
endogenous opioids. Continuous footshock stress produced 
a naloxone-insensitive analgesia, which is thus nonopioid in 
nature. Interestingly, only the opioid form of stress-induced 
analgesia was enhanced by fetal ethanol exposure, while 
the nonopioid form was completely unaffected. Moreover,  
this potentiation of stress-induced opioid analgesia in 
prenatal ethanol-exposed rats is probably not due to 
impaired performance in the tail-flick test, since these rats 
did not differ from controls when tested before stress or 
following continuous footshock stress. Thus, the potentia- 
tion of stress-induced analgesia, as indexed by increased 
tail-flick latencies, is specific to the type of stress admin- 
istered. 
It is possible that the potentiated analgesia seen in the 
prenatal ethanol-exposed rats could represent the summa- 
tion of a nonopioid analgesic response with the opioid 
analgesia normally seen following 10-rain intermittent 
footshock stress. To examine this possibility, we looked at 
the analgesic response following the administration of 
naloxone, which would not be expected to reduce analgesia 
resulting from nonopioid mechanisms. As shown in Fig. 3, 
the stress-induced analgesia was attenuated to a similar 
degree in all groups of rats, indicating that the potentiation 
seen in the prenatal ethanol-exposed rats was indeed opioid 
in nature. These results suggest that fetal exposure to 
ethanol produces long-lasting perturbations in the endog- 
enous opioid systems which subserve this analgesic re- 
sponse. Alternatively, the critical alterations may not be in 
the opioid systems themselves, but in another neurochem- 
ical system which modulates their expression. 
While it is suggested that prenatal exposure to ethanol 
alters endogenous opioid systems, precisely which of these 
systems are affected and to what degree is not known. 
Accumulating evidence indicates that there may be wide- 
spread alterations in opioid systems following fetal ethanol 
exposure. There have been reports of elevations in brain 
levels of two opioid peptides; fl-endorphin in the midbrain 
and hindbrain (Shoemaker et al. 1983a), and met- and 
leu-enkephalin in the basal ganglia (McGivern et al. 1983). 
In addition, Govoni et al. (1983) reported that children 
4 - 1 2  years of age, who were born to chronic alcoholic 
mothers, had decreased levels of met-enkephalin-like 
immunoreactivity in plasma compared to age-matched 
controls. Alterations in opiate receptors have also been 
documented:  Shoemaker et al. (1983b) found a decreased 
number  of both high- and low-affinity sites for dihydro- 
morphine in newborn rat pups prenatally exposed to 
ethanol and Shah and West (1983) reported decreased 
3H-naloxone binding in the striatum of prenatal ethanol-ex- 
posed rats during postnatal days 4 -25 .  
In addition, we have been using morphine as a 
pharmacological probe to assess the functioning of the 
opioid systems: Three responses to morphine (hypother- 
mia, corticosteroid release, and analgesia) were all aug- 
mented in adult rats prenatally exposed to ethanol (Nelson 
et al. 1983). These findings add further support to the 
contention that there are widespread and long-lasting 
alterations in the endogenous opioid systems following fetal 
ethanol exposure. 
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